Font Size: a A A
Keyword [palbociclib]
Result: 1 - 20 | Page: 1 of 2
1. Synthesis Process Of Palbociclib
2. The Research On The Preparation And Quality Of Palbociclib Capsules
3. Study On The Combination Of Anti Folic Acid Drugs And Specific Cell Cycle Inhibitors In The Treatment Of Bladder Cancer
4. Investigating The Therapeutic Effect Of Olaparib And Palbociclib In Ovarian Cancer And Its Underlying Mechanism
5. Antitumor Activity Of A Novel CDK4/6 Inhibitor,SHR6390,in RB Positive Tumors
6. Combined Androgen Receptor Blockade Overcomes The Resistance Of Breast Cancer Cells To Palbociclib
7. Study Of Cell Proliferation In Acute T Cell Leukemia With High Expression Of Notch1 Gene
8. The Interaction Between CDK4 And PFKFB3 Is Crucial For The Palbociclib Sensitivity
9. Synthetic Routes Of Cell Cycle-dependent Kinase Inhibitor Palbociclib And Design,Synthesis And Bioactivity Study Of Its Derivatives
10. HOTAIR-EZH2 Inhibitor AC1Q3QWB Upregulates CWF19L1 And Enhance Cell Cycle Inhibition Of CDK4/6 Inhibitor Palbociclib In Glioma
11. Synergistic Inhibition Of Osteosarcoma By Polyalanine Thermo-sensitive Hydrogel In Situ Sustained-release Palbociclib And Doxorubicin
12. Radiosensitivity Effect Of Palbociclib In Breast Cancer
13. Delivery and efficacy of CDK4/6 inhibitors in the treatment of brain tumors
14. Study On Protective Effect Of CDK4/6 Inhibitor Palbociclib In Diabetic Cardiomyopathy And Their Mechanisms
15. Investigation On Anti-tumor Activity Of CDK4/6 Inhibitor In Non-small Cell Lung Cancer Cell Lines And The Mechanism Of Overcoming The Third Generation EGFR-TKI Acquired Resistance
16. The Mechanism Of Palbociclib Inhibiting Synergistically With Lapatinib Or Herceptin In The Proliferation Of Breast Cancer Stem Cells
17. CDK4/6 Inhibitor Palbociclib Enhances The Sensitivity Of RB-Proficient Triple-Negative Breast Cancer To Cisplatin
18. The Anti-tumor Effect And Mechanism Of CDK4/6 Inhibitor Palbociclib In Small Cell Lungcancer Cell Lins
19. Treatment Of Palbociclib In Hormone Receptor Positive Breast Cancer: A Real-world Study And Efficacy Prediction Model
20. The Clinical Drugs Palbociclib And Pimozide Suppress IgE?mediated Mast Cell Activation In Vitro And In Vivo
  <<First  <Prev  Next>  Last>>  Jump to